Literature DB >> 22637532

Membrane-bound Kit ligand regulates melanocyte adhesion and survival, providing physical interaction with an intraepithelial niche.

Severine Tabone-Eglinger1, Monique Wehrle-Haller, Nicole Aebischer, Marie-Claude Jacquier, Bernhard Wehrle-Haller.   

Abstract

Morphogenesis, as illustrated by melanocyte migration and homing to the skin, requires cadherin adhesion, integrin-dependent migration and Kit-ligand growth factor signaling. However, it is not known how Kit ligand regulates integrin or cadherin-dependent intraepidermal melanocyte behavior. To answer this question, we developed specific 2-dimensional (2D) and 3D culture systems analyzing how soluble or immobilized Kit-ligand-regulated melanocyte migration on vitronectin and laminin, or within a monolayer of kidney epithelial cells. In a 2D system, soluble Kit ligand stimulated integrin-dependent melanoblast migration and chemotaxis and accelerated integrin turnover. In contrast, immobilized, but not soluble, Kit ligand, enhanced integrin-dependent melanocyte spreading on suboptimal laminin concentrations. In 3D, membrane-bound Kit ligand induced intraepithelial melanocyte proliferation, survival, and tight adhesion to epithelial cells, while cleavable Kit ligand was less effective. In contrast, melanocyte motility was independent of membrane-bound Kit ligand, but increased in the presence of the cleavable Kit-ligand isoform. Transmembrane-dimerization or basolateral-targeting mutants of Kit ligand altered intraepithelial melanocyte localization, survival, and adhesion to epithelial cells. These data and the identification of c-kit/Kit-ligand clusters at cell contacts suggest that membrane-bound Kit ligand captures cell surface-expressed c-kit, providing mechanical anchoring and survival signaling within intraepithelial niches, and thereby defining a new mechanism for melanocyte homeostasis and requirement for environmental niches.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22637532     DOI: 10.1096/fj.12-206045

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  8 in total

Review 1.  Melanocyte stem cells as potential therapeutics in skin disorders.

Authors:  Ju Hee Lee; David E Fisher
Journal:  Expert Opin Biol Ther       Date:  2014-08-08       Impact factor: 4.388

Review 2.  Skin as a living coloring book: how epithelial cells create patterns of pigmentation.

Authors:  Lorin Weiner; Wenyu Fu; William J Chirico; Janice L Brissette
Journal:  Pigment Cell Melanoma Res       Date:  2014-09-01       Impact factor: 4.693

Review 3.  The melanocyte lineage in development and disease.

Authors:  Richard L Mort; Ian J Jackson; E Elizabeth Patton
Journal:  Development       Date:  2015-02-15       Impact factor: 6.868

4.  In vivo coherent Raman imaging of the melanomagenesis-associated pigment pheomelanin.

Authors:  Hequn Wang; Sam Osseiran; Vivien Igras; Alexander J Nichols; Elisabeth M Roider; Joachim Pruessner; Hensin Tsao; David E Fisher; Conor L Evans
Journal:  Sci Rep       Date:  2016-11-28       Impact factor: 4.379

Review 5.  Understanding Melanocyte Stem Cells for Disease Modeling and Regenerative Medicine Applications.

Authors:  Amber N Mull; Ashwini Zolekar; Yu-Chieh Wang
Journal:  Int J Mol Sci       Date:  2015-12-21       Impact factor: 5.923

Review 6.  Metastatic melanoma - a review of current and future drugs.

Authors:  Tiago Rodrigues Velho
Journal:  Drugs Context       Date:  2012-11-19

7.  Self-Generated Gradients Yield Exceptionally Robust Steering Cues.

Authors:  Luke Tweedy; Robert H Insall
Journal:  Front Cell Dev Biol       Date:  2020-03-05

8.  Stem cell factor is implicated in microenvironmental interactions and cellular dynamics of chronic lymphocytic leukemia.

Authors:  George I Gavriilidis; Stavroula Ntoufa; Nikos Papakonstantinou; Konstantia Kotta; Triantafyllia Koletsa; Elisavet Chartomatsidou; Theodoros Moysiadis; Niki Stavroyianni; Achilles Anagnostopoulos; Eleni Papadaki; Asterios S Tsiftsoglou; Kostas Stamatopoulos
Journal:  Haematologica       Date:  2021-03-01       Impact factor: 9.941

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.